Fresenius Medical Care AG ADR (FMS)
NYSE: FMSHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 20.75 +0.29%
FMS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $11.01B
- P/E (TTM)
- 10.66
- Forward P/E
- 6.92
- EPS (TTM)
- $1.94
- Dividend yield
- 7.20% ($1.49)
- Ex-dividend date
- May 22, 2026
- 52-week range
- 20.02 – 27.64
- Day range
- 20.50 – 22.67
- Volume / Avg
- 3.24M / 696.44K
- Beta
- —
- Shares outstanding
- 532.22M
- Next earnings
- Nov 3, 2026
52-week range
FMS stock today
Shares of Fresenius Medical Care (FMS) finished lower on Oct 7 at $20.69, a drop of 7.72% or $1.73 per share, versus the S&P 500's 0.22% decline. Volume was 4.7x the average at 3.24M shares, a sign of unusually heavy trading. At this level, FMS sits near the bottom of its 52-week range of $20.02 to $27.64: 25.1% below the high, set on Oct 9, 2025 and 3.3% above the low.
FMS is down 13.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 22.9%. At 10.7x trailing earnings, Fresenius Medical Care trades below the peer-group median of 28.0x. Its forward P/E of 6.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Fresenius Medical Care's next earnings report is expected on Nov 3, 2026.
Fresenius Medical Care pays an annual dividend of $1.49 per share, a 7.20% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Fresenius Medical Care
Company profileFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Ms. Helen Giza
- Headquarters
- Bad Homburg
- Employees
- 107,226
- Website
- freseniusmedicalcare.com
Financial highlights
Full financialsIn fiscal 2013, Fresenius Medical Care generated $4.97 billion in revenue, down 64.0% from fiscal 2012, the first decline in the 7 years shown. Net income was $1.11 billion (-6.5% year over year), for a net margin of 22.3% versus a median of 8.3% in the prior 5 years. Gross margin was 95.3% (up from 33.3%) and operating margin 45.4%.
| Fiscal year | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|
| Revenue | $4.97B | $13.80B | $12.57B | $11.84B | $11.25B |
| Growth | -63.98% | +9.78% | +6.13% | +5.31% | +5.99% |
| Net income | $1.11B | $1.19B | $1.07B | $978.52M | $891.14M |
| EPS (diluted) | $3.65 | $3.87 | $3.51 | $3.24 | $2.99 |
Analyst forecast
ForecastConsensus (7 analysts)
hold
Avg. price target
$23.43+13.24%
- Strong buy 1
- Buy 0
- Hold 3
- Sell 1
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 3, 2026
Dividends
Dividend history- Annual dividend
- $1.49
- Dividend yield
- 7.20%
- Last payment
- $0.872
- Ex-dividend date
- May 22, 2026
FMS news
All FMS newsFresenius Medical Care peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DVADaVita Inc. | 176.78 | -2.01% | $11.28B | vs FMS |
| SHCSotera Health Company | 17.90 | -1.92% | $5.11B | vs FMS |
| PGNYProgyny Inc. | 27.55 | +6.33% | $2.11B | vs FMS |
| AGLagilon health inc. | 85.70 | +2.76% | $1.44B | vs FMS |
| VMDViemed Healthcare Inc. | 9.37 | +0.43% | $356.89M | vs FMS |
| PARKPark Dental Partners Inc. | 20.94 | +1.26% | $99.58M | vs FMS |
| CCELCryo-Cell International Inc. | 3.91 | +0.77% | $31.52M | vs FMS |
| MGRXMangoceuticals Inc. | 0.4437 | -1.40% | $9.57M | vs FMS |
Indexes, lists and sector
Appears in lists
Fresenius Medical Care stock FAQ
What is Fresenius Medical Care's stock price today?
FMS last traded at $20.69 as of Oct 7, 4:00 PM EDT, down 7.72% on the day. Prices are delayed at least 15 minutes.
Does Fresenius Medical Care pay a dividend?
Yes. Fresenius Medical Care pays $1.49 per share annually, a 7.20% yield. The most recent dividend of $0.872 had an ex-dividend date of May 22, 2026.
When is Fresenius Medical Care's next earnings date?
Fresenius Medical Care is expected to report earnings on Tuesday, November 3, 2026.
What is FMS's P/E ratio?
FMS trades at a trailing P/E ratio of 10.66 and a forward P/E of 6.92, compared with a median of 28.0 for its closest peers.
Who is Fresenius Medical Care's CEO?
Ms. Helen Giza is the chief executive officer of Fresenius Medical Care AG ADR, which has about 107,226 employees.
Has FMS ever split its stock?
Yes. The most recent FMS stock split was a 2-for-1 split on Dec 4, 2012.
What is the FMS 52-week high?
The 52-week high for FMS is $27.64 and the 52-week low is $20.02. The stock is currently 25.1% below its high.